Development of a reliable microRNA based electrochemical genosensor for monitoring of miR-146a, as key regulatory agent of neurodegenerative disease.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Aug 2019
Historique:
received: 27 02 2019
revised: 07 05 2019
accepted: 08 05 2019
pubmed: 15 5 2019
medline: 18 12 2019
entrez: 15 5 2019
Statut: ppublish

Résumé

A MicroRNA (miR) based electrochemical method for quantification of miR-146a, a known biomarker for neurodegenerative disease, was developed. In this bioassay, the capture microRNA (C-miR) was self-assembled on the gold surface and used for quantification of target microRNA (T-miR) of miR-146a. For this purpose, an optimized concentration of C-miR was immobilized on the surface of gold electrode and used for capture of target analyte (T-miR). All of preparation steps were characterized by electrochemical techniques (cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS)) and atomic force microscopy (AFM). At the optimized conditions, the linear dynamic range, limit of quantification and relative standard deviation of the proposed bioassay were obtained as 10 pM to 1 μM, 10 pM and 1.59%, respectively. The unprocessed human serum sample was used as a real sample and the results fully confirm that the designed microRNA based biosensor is capable for detection of miR-146a as neurodegenerative disease biomarker. The developed method offers a more precise and high sensitive tool to be used in clinical applications for early detection of neurodegenerative disease like Alzheimer's and Parkinson.

Identifiants

pubmed: 31082423
pii: S0141-8130(19)31527-2
doi: 10.1016/j.ijbiomac.2019.05.061
pii:
doi:

Substances chimiques

MIRN146 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

695-703

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Balal Khalilzadeh (B)

Stem Cell Research Center (SCRC), Tabriz University of Medical Sciences, Tabriz, Iran; Biosensors and Bioelectronics Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. Electronic address: khalilzadehb@tbzmed.ac.ir.

Mohammad Rashidi (M)

Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Sciences, Tabriz, Iran.

Alireza Soleimanian (A)

Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Habib Tajalli (H)

Biophotonic Research Center, Islamic Azad University, Tabriz Branch, Tabtiz, Iran.

Gulsah Saydan Kanberoglu (GS)

Department of Chemistry, Faculty of Sciences, Van Yuzuncu Yil University, 65080, Van, Turkey.

Behzad Baradaran (B)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad-Reza Rashidi (MR)

Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH